Sodium dodecyl sulfate - Polyacrylamide gel electrophoresis and Forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands

被引:70
作者
Li, E [1 ]
You, M [1 ]
Hristova, K [1 ]
机构
[1] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
关键词
D O I
10.1021/bi048480k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lateral dimerization of membrane proteins has evolved as a means of signal transduction across the plasma membrane for all receptor tyrosine kinases (RTKs). The transmembrane (TM) domains of RTKs are proposed to play an important role in the dimerization process. We have investigated whether the TM domains of one RTK, fibroblast growth factor receptor 3 (FGFR3), dimerize in lipid vesicles in the absence of the extracellular domains and ligands. We have performed sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with peptides produced via solid-phase peptide synthesis that correspond to the TM domain of FGFR3. We have carried out Forster resonance energy transfer (FRET) measurements using two donor-acceptor pairs, fluorescein/rhodamine and Cy3/Cy5, as a function of peptide concentration and donor-to-acceptor mole ratios. Our results suggest that FGFR3 TM domains form sequence-specific dimers in lipid bilayers. However, the dimerization propensity of FGFR3 TM domain is much weaker than the dimerization propensity of glycophorin A (GpA), the well-characterized "membrane dimer standard". We discuss our findings in the context of cell signaling across the plasma membrane and diseases or disorders that occur due to single amino acid mutations in the TM domain of FGFR3.
引用
收藏
页码:352 / 360
页数:9
相关论文
共 50 条
[1]   GLYCOPHORIN-A HELICAL TRANSMEMBRANE DOMAINS DIMERIZE IN PHOSPHOLIPID-BILAYERS - A RESONANCE ENERGY-TRANSFER STUDY [J].
ADAIR, BD ;
ENGELMAN, DM .
BIOCHEMISTRY, 1994, 33 (18) :5539-5544
[2]  
Bange J, 2002, CANCER RES, V62, P840
[3]   Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase [J].
Bell, CA ;
Tynan, JA ;
Hart, KC ;
Meyer, AN ;
Robertson, SC ;
Donoghue, DJ .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (10) :3589-3599
[4]   Purification of the Escherichia coli ammonium transporter AmtB reveals a trimeric stoichiometry [J].
Blakey, D ;
Leech, A ;
Thomas, GH ;
Coutts, G ;
Findlay, K ;
Merrick, M .
BIOCHEMICAL JOURNAL, 2002, 364 :527-535
[5]   Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].
Cappellen, D ;
De Oliveira, C ;
Ricol, D ;
de Medina, SGD ;
Bourdin, J ;
Sastre-Garau, X ;
Chopin, D ;
Thiery, JP ;
Radvanyi, F .
NATURE GENETICS, 1999, 23 (01) :18-20
[6]  
Clegg R. M, 1996, Fluorescence Imaging Spectroscopy and Microscopy
[7]  
Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6
[8]   Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].
Colvin, JS ;
Bohne, BA ;
Harding, GW ;
McEwen, DG ;
Ornitz, DM .
NATURE GENETICS, 1996, 12 (04) :390-397
[9]   Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers [J].
Cornea, RL ;
Jones, LR ;
Autry, JM ;
Thomas, DD .
BIOCHEMISTRY, 1997, 36 (10) :2960-2967
[10]   Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].
Deng, CX ;
WynshawBoris, A ;
Zhou, F ;
Kuo, A ;
Leder, P .
CELL, 1996, 84 (06) :911-921